Charles Bonnet syndrome improves when treatment is effective in age-related macular degeneration

British Journal of Ophthalmology

Volumn 95, Issue 2, 2011, Pages 291-292

  Singh, Amardeep ^a   Sorensen T L ^a  

^a Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB;

CHARLES BONNET SYNDROME; DEMENTIA; FOLLOW UP; HALLUCINATION; HUMAN; LETTER; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; FEMALE; HALLUCINATIONS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SYNDROME; VISION DISORDERS; VISUAL ACUITY;

EID: 79251493351     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.179465     Document Type: Letter

References (6)

1. Schadlu AF, Schadlu R, Shepard JB III. Charles Bonnet syndrome: a review. Curr Opin Ophthalmol 2009;20:219-22.
2. Holroyd S, Rabins PV, Finkelstein D, et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992;142:1701-6.
3. Menon GJ. Complex visual hallucinations in the visually impaired: a structured history-taking approach. Arch Ophthalmol 2005;123:349-55.
4. Holroyd A, Rabins PV. A three-year follow-up study of visual hallucinations in patients with macular degeneration. J Nerv Ment Dis 1996;184:188-9.
5. Crumbliss KE, Taussig MG, Jay WM. Vision rehabilitation and Charles Bonnet Syndrome. Semin Ophthalmol 2008;23:121-6.
6. Madill SA, Lascaratos G, Arden GB, et al. Perceived color of hallucinations in the Charles Bonnet Syndrome in related to residual color contrast sensitivity. J Neuro Ophthalmol 2009;29:192-6.